Saida, Takahiko
Kira, Jun-Ichi
Kishida, Shuji
Yamamura, Takashi
Ohtsuka, Nobuhisa
Dong, Qunming
Tibung, J. T.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis
https://doi.org/10.1007/s40120-016-0062-4
Funding for this research was provided by:
Biogen
Article History
Received: 10 October 2016
First Online: 11 January 2017